Updated EAU Guidelines for Clear Cell Renal Cancer Patients Who Fail VEGF Targeted Therapy - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue European Urology Année : 2016

Updated EAU Guidelines for Clear Cell Renal Cancer Patients Who Fail VEGF Targeted Therapy

Résumé

The European Association of Urology renal cancer guidelines have been updated to recommend nivolumab and cabozantinib over the previous standard of care in patients who have failed one or more lines of VEGF targeted therapy.
Fichier non déposé

Dates et versions

hal-01220642 , version 1 (26-10-2015)

Identifiants

Citer

Thomas Powles, Michael Staehler, Börje Ljungberg, Karim Bensalah, Steven E. Canfield, et al.. Updated EAU Guidelines for Clear Cell Renal Cancer Patients Who Fail VEGF Targeted Therapy. European Urology, 2016, 69 (1), pp.4-6. ⟨10.1016/j.eururo.2015.10.017⟩. ⟨hal-01220642⟩
60 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More